http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012500650-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C11C3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23D9-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23D9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23D9-007 |
| filingDate | 2009-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2012500650-A |
| titleOfInvention | Edible oil containing sn-2 myristate |
| abstract | A nutritional fat or oil-based composition for increasing HDL cholesterol in human plasma, decreasing LDL cholesterol, and lowering the LDL / HDL cholesterol ratio is described. The composition advantageously comprises at least 1% by weight of myristic acid esterified at the sn-2 position of the triglyceride molecule, comprises between 10% and 40% by weight of linoleic acid, and further comprises 30% oleic acid. Between 5% and 65% by weight and between 15% and 40% by weight of total saturated fatty acids can be included. The ratio of sn-2 myristic acid to sn-2 palmitic acid is typically greater than 1: 1 and the sum of the weight percentages of saturated, monounsaturated and polyunsaturated fatty acids is equal to 100% . If desired, the composition is substantially free of cholesterol. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7044342-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018188381-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019181822-A1 |
| priorityDate | 2008-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 366.